サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1311102

バイオディフェンスの世界市場規模調査・予測、製品別、地域別分析、2023-2030年

Global Biodefense Market Size Study & Forecast, By Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear, Others), and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
バイオディフェンスの世界市場規模調査・予測、製品別、地域別分析、2023-2030年
出版日: 2023年07月11日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオディフェンス市場は、2022年に約152億米ドルと評価され、予測期間2023-2030年には5.0％以上の健全な成長率で成長すると予測されています。

バイオディフェンスとは一般的に、生物学的病原体の意図的な兵器としての利用や、自然発生する感染症の発生といった生物学的脅威から身を守るために実施される戦略、対策、行動のことを指します。これらの対策は、感染症や生物毒に対する国家のバイオセキュリティ防御を再確立する必要性に応じて実施されます。生物防御は、人、動物、または環境を殺傷または感染させる意図で生物戦に用いられます。バイオテロでは通常、生物が生物兵器として使用されます。これらには一般に、細菌、ウイルス、真菌、毒素が含まれ、意図的に利用されて人々を感染させたり殺したりし、社会や経済に大混乱をもたらします。民間企業による投資の増加、生物製剤の脅威の増大、公衆衛生への備えへの注目の高まり、早期発見と対応の重視の高まり、バイオディフェンスにおけるドローンとロボットの使用急増は、世界中の市場需要をもたらしている主な要因です。

さらに、各国政府はバイオテロ攻撃に備えるため、ワクチンの研究開発に多額の資金を提供しています。あらゆる形態のバイオテロに備える政府のイニシアチブの結果、バイオディフェンス分野で活動する製薬企業には成長の大きなチャンスがあります。2022年10月、アメリカ政府はパンデミックやその他の生物学的脅威に対する新たな防衛戦略を策定しました。2022年6月には、米国政府が潜在的な健康被害にどのように対処すべきかについて、改訂された国家生物防衛戦略が的確な指示を出すと予想されています。また、エマージェント・バイオサイエンス社は、2022年第1四半期の炭疽菌ワクチンの売上が2021年第1四半期より4,860万米ドル増加したと報告しました。米国政府（USG）、特に戦略的国家備蓄（SNS）への納入時期が成長の主な要因です。さらに、同事業は2023年3月までAV7909用量をさらに供給するため、2021年9月に推定3億9,900万米ドルでAV7909（炭疽菌ワクチン吸着・アジュバント）契約の修正を受けた。このように、バイオディフェンス戦略に向けた政府の注力と資金調達の増加は、市場の成長にプラスの影響を及ぼしています。さらに、急速な技術進歩や研究開発活動の活発化は、予測期間中の市場成長にさまざまな有利な機会をもたらしています。しかし、新興国や低開発国での市場開拓が遅れていること、資金や予算が限られていることが、2023年から2030年の予測期間を通じて市場成長の課題となっています。

バイオディフェンスの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、2022年に最大の市場シェアを占め、市場を独占しました。これは、国民の間で意識が高まっていること、連邦政府からの資金援助が多いこと、技術進歩が進んでいることによる。一方、アジア太平洋地域は、今後数年間で最も急成長する地域と予想されます。研究開発への投資の急増、有害な生物学的物質の脅威の高まり、同地域で確立されたワクチン生産施設などが、同地域全体の市場需要を大きく押し上げています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・地域別市場推計・予測、2020-2030年
  • 主要動向
  • 調査手法
  • 調査前提条件

第2章 世界のバイオディフェンス市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 世界のバイオディフェンス市場力学

  • バイオディフェンス市場の影響分析（2020-2030年）
    • 市場促進要因
      • 生物製剤の脅威の増大
      • バイオディフェンス戦略に向けた政府の注力と資金の増加
    • 市場の課題
      • 限られた資金と予算の制約
      • 発展途上国や低開発国での市場浸透度の低さ
    • 市場機会
      • 急速な技術進歩
      • 研究開発の活発化

第4章 世界のバイオディフェンス市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治的
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 世界のバイオディフェンス市場：製品別

  • 市場スナップショット
  • バイオディフェンスの世界市場：製品別、実績 - ポテンシャル分析
  • バイオディフェンスの世界市場：製品別推定・予測、2020～2030年
  • バイオディフェンス市場、サブセグメント分析
    • 炭疽菌
    • 天然痘
    • ボツリヌス中毒
    • 放射線/核
    • その他

第6章 世界のバイオディフェンス市場、地域分析

  • 主要国
  • 主な新興国
  • バイオディフェンス市場、地域別市場スナップショット
  • 北米
    • 米国
      • 製品別の推定・予測、2020-2030年
    • カナダ
  • 欧州バイオディフェンス市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋バイオディフェンス市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのバイオディフェンス市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第7章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • XOMA corporation
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Altimmune Inc.
    • Emergent Biosolutions Inc.
    • Dynavax Technologies Corporation.
    • SIGA Technologies.
    • Elusys Therapeutics Inc.
    • Ichor Medical Systems.
    • Dynport Vaccine Company.
    • Cleveland Biolabs.
    • Bavarian Nordic.

第8章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Biodefense Market, report scope
  • TABLE 2. Global Biodefense Market estimates & forecasts by region 2020-2030 (USD Billion)
  • TABLE 3. Global Biodefense Market estimates & forecasts by Product 2020-2030 (USD Billion)
  • TABLE 4. Global Biodefense Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 5. Global Biodefense Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 6. Global Biodefense Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Biodefense Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Biodefense Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Biodefense Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Biodefense Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Biodefense Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Biodefense Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Biodefense Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. U.S. Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. U.S. Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 16. U.S. Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 17. Canada Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 18. Canada Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. UK Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 21. UK Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. Germany Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 24. Germany Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. France Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 27. France Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. Italy Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 30. Italy Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Spain Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 33. Spain Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. RoE Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 36. RoE Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. China Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 39. China Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. India Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 42. India Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. Japan Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 45. Japan Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. South Korea Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 48. South Korea Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. Australia Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 51. Australia Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. RoAPAC Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 54. RoAPAC Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. Brazil Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 57. Brazil Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Mexico Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 60. Mexico Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. RoLA Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 63. RoLA Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. Saudi Arabia Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 66. South Africa Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. RoMEA Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. List of secondary sources, used in the study of global Biodefense Market
  • TABLE 69. List of primary sources, used in the study of global Biodefense Market
  • TABLE 70. Years considered for the study
  • TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Biodefense Market, research methodology
  • FIG 2. Global Biodefense Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Biodefense Market, key trends 2022
  • FIG 5. Global Biodefense Market, growth prospects 2023-2030
  • FIG 6. Global Biodefense Market, porters 5 force model
  • FIG 7. Global Biodefense Market, pest analysis
  • FIG 8. Global Biodefense Market, value chain analysis
  • FIG 9. Global Biodefense Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Biodefense Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Biodefense Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Biodefense Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Biodefense Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Biodefense Market, regional snapshot 2020 & 2030
  • FIG 15. North America Biodefense Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Biodefense Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Biodefense Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Biodefense Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Biodefense Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Biodefense Market is valued approximately at USD 15.2 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.0% over the forecast period 2023-2030. Biodefense is generally described as those strategies, measures, and actions that are conducted to protect against biological threats such as the deliberate utilization of biological agents as weapons and naturally occurring outbreaks of infectious diseases. These measures are conducted in response to the need to reestablish a nation's biosecurity defenses against infectious diseases or biological poisons. The biodefense is used in biological warfare with the intention of killing or infecting people, animals, or the environment. Living organisms are typically used as biological agents in bioterrorism. These generally include bacteria, viruses, fungi, or toxins that are utilized on purpose to infect and kill people, wreaking havoc on society and the economy. The growing investment from private players, increasing threat of biological agents, rising focus on public health preparedness, rising emphasis on early detection and response and surging use of drones and robots in biodefense are the key factors that are attributing to the market demand around the world.

Furthermore, governments are substantially funding vaccine research and development to prepare for any bioterrorism strikes. As a result of government initiatives to be prepared for any form of bioterrorism, pharmaceutical businesses working in the biodefense sector have enormous chances to grow. In October 2022, the Government of America has developed a new defense strategy against pandemic and other biological threats. A revamped National Biodefense Strategy was anticipated to offer precise instructions on how the US government ought to react to potential health dangers in June 2022. Also, Emergent Bioscience reported an increase of USD 48.6 million in Q1 2022 Anthrax vaccine revenue over Q1 2021. The timing of delivery to the United States government (USG), specifically the Strategic National Stockpile (SNS), is a major factor in the growth. Additionally, the business got an AV7909 (Anthrax Vaccine Adsorbed, Adjuvanted) contract amendment in September 2021 for an estimated USD 399 million to supply more AV7909 doses through March 2023. Thereby, rising government focus and funding towards biodefense strategies are exhibiting a positive influence on the market growth. Moreover, the rapid technological advancement, as well as the growing research and development activities present various lucrative opportunities for the market growth over the forecast years. However, the Low market penetration in developing and underdeveloped countries and the limited funding and budget constraints are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Biodefense Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the growing awareness among the population, the presence of high federal funding, along with increasing technological advancements. Whereas, Asia Pacific is expected to account as fastest growing region over the forecast years. The surging investments in R&D, the rising threat of harmful biological materials, as well as well-established vaccine production facilities in the region are significantly propelling the market demand across the region.

Major market players included in this report are:

  • XOMA corporation
  • Altimmune Inc.
  • Emergent Biosolutions Inc.
  • Dynavax Technologies Corporation.
  • SIGA Technologies.
  • Elusys Therapeutics Inc.
  • Ichor Medical Systems.
  • Dynport Vaccine Company.
  • Cleveland Biolabs.
  • Bavarian Nordic.

Recent Developments in the Market:

  • In May 2022, Emergent BioSolutions Inc. announced that it had signed a legal agreement with Chimerix, Inc. to acquire all Chimerix's exclusive worldwide rights to the antiviral drug TEMBEXA (brincidofovir), which the FDA first approved for use in treating smallpox in people of all ages.
  • In June 2022, Emergent BioSolutions Inc. stated that the US Food and Drug Administration (FDA) had accepted the Biologics Licence Application (BLA) for AV7909 (Anthrax Vaccine Adsorbed, Adjuvanted) for review.

Global Biodefense Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Anthrax
  • Smallpox
  • Botulism
  • Radiation/Nuclear
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Biodefense Market, by region, 2020-2030 (USD Billion)
    • 1.2.2. Biodefense Market, by Product, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Biodefense Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Biodefense Market Dynamics

  • 3.1. Biodefense Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing threat of biological agents
      • 3.1.1.2. Rising government focus and funding towards biodefense strategies
    • 3.1.2. Market Challenges
      • 3.1.2.1. Limited funding and budget constraints
      • 3.1.2.2. Low market penetration in developing and underdeveloped countries
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rapid technological advancements
      • 3.1.3.2. Growing research and development activities

Chapter 4. Global Biodefense Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economic
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Biodefense Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Biodefense Market by Product, Performance - Potential Analysis
  • 5.3. Global Biodefense Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4. Biodefense Market, Sub Segment Analysis
    • 5.4.1. Anthrax
    • 5.4.2. Smallpox
    • 5.4.3. Botulism
    • 5.4.4. Radiation/Nuclear
    • 5.4.5. Others

Chapter 6. Global Biodefense Market, Regional Analysis

  • 6.1. Top Leading Countries
  • 6.2. Top Emerging Countries
  • 6.3. Biodefense Market, Regional Market Snapshot
  • 6.4. North America Biodefense Market
    • 6.4.1. U.S. Biodefense Market
      • 6.4.1.1. Product breakdown estimates & forecasts, 2020-2030
    • 6.4.2. Canada Biodefense Market
  • 6.5. Europe Biodefense Market Snapshot
    • 6.5.1. U.K. Biodefense Market
    • 6.5.2. Germany Biodefense Market
    • 6.5.3. France Biodefense Market
    • 6.5.4. Spain Biodefense Market
    • 6.5.5. Italy Biodefense Market
    • 6.5.6. Rest of Europe Biodefense Market
  • 6.6. Asia-Pacific Biodefense Market Snapshot
    • 6.6.1. China Biodefense Market
    • 6.6.2. India Biodefense Market
    • 6.6.3. Japan Biodefense Market
    • 6.6.4. Australia Biodefense Market
    • 6.6.5. South Korea Biodefense Market
    • 6.6.6. Rest of Asia Pacific Biodefense Market
  • 6.7. Latin America Biodefense Market Snapshot
    • 6.7.1. Brazil Biodefense Market
    • 6.7.2. Mexico Biodefense Market
  • 6.8. Middle East & Africa Biodefense Market
    • 6.8.1. Saudi Arabia Biodefense Market
    • 6.8.2. South Africa Biodefense Market
    • 6.8.3. Rest of Middle East & Africa Biodefense Market

Chapter 7. Competitive Intelligence

  • 7.1. Key Company SWOT Analysis
    • 7.1.1. Company 1
    • 7.1.2. Company 2
    • 7.1.3. Company 3
  • 7.2. Top Market Strategies
  • 7.3. Company Profiles
    • 7.3.1. XOMA corporation
      • 7.3.1.1. Key Information
      • 7.3.1.2. Overview
      • 7.3.1.3. Financial (Subject to Data Availability)
      • 7.3.1.4. Product Summary
      • 7.3.1.5. Recent Developments
    • 7.3.2. Altimmune Inc.
    • 7.3.3. Emergent Biosolutions Inc.
    • 7.3.4. Dynavax Technologies Corporation.
    • 7.3.5. SIGA Technologies.
    • 7.3.6. Elusys Therapeutics Inc.
    • 7.3.7. Ichor Medical Systems.
    • 7.3.8. Dynport Vaccine Company.
    • 7.3.9. Cleveland Biolabs.
    • 7.3.10. Bavarian Nordic.

Chapter 8. Research Process

  • 8.1. Research Process
    • 8.1.1. Data Mining
    • 8.1.2. Analysis
    • 8.1.3. Market Estimation
    • 8.1.4. Validation
    • 8.1.5. Publishing
  • 8.2. Research Attributes
  • 8.3. Research Assumption